172 related articles for article (PubMed ID: 19047917)
1. Murine model for cystic fibrosis bone disease demonstrates osteopenia and sex-related differences in bone formation.
Pashuck TD; Franz SE; Altman MK; Wasserfall CH; Atkinson MA; Wronski TJ; Flotte TR; Stalvey MS
Pediatr Res; 2009 Mar; 65(3):311-6. PubMed ID: 19047917
[TBL] [Abstract][Full Text] [Related]
2. Severe osteopenia in CFTR-null mice.
Dif F; Marty C; Baudoin C; de Vernejoul MC; Levi G
Bone; 2004 Sep; 35(3):595-603. PubMed ID: 15336594
[TBL] [Abstract][Full Text] [Related]
3. The F508del mutation in cystic fibrosis transmembrane conductance regulator gene impacts bone formation.
Le Henaff C; Gimenez A; Haÿ E; Marty C; Marie P; Jacquot J
Am J Pathol; 2012 May; 180(5):2068-75. PubMed ID: 22449949
[TBL] [Abstract][Full Text] [Related]
4. Genetic deletion of keratin 8 corrects the altered bone formation and osteopenia in a mouse model of cystic fibrosis.
Le Henaff C; Faria Da Cunha M; Hatton A; Tondelier D; Marty C; Collet C; Zarka M; Geoffroy V; Zatloukal K; Laplantine E; Edelman A; Sermet-Gaudelus I; Marie PJ
Hum Mol Genet; 2016 Apr; 25(7):1281-93. PubMed ID: 26769674
[TBL] [Abstract][Full Text] [Related]
5. CFTR deletion affects mouse osteoblasts in a gender-specific manner.
Orlando V; Morin G; Laffont A; Lénart D; Solórzano Barrera C; Mustafy T; Sankhe S; Villemure I; Mailhot G
J Cell Physiol; 2020 Oct; 235(10):6736-6753. PubMed ID: 31985038
[TBL] [Abstract][Full Text] [Related]
6. Persistent osteopenia in adult cystic fibrosis transmembrane conductance regulator-deficient mice.
Haston CK; Li W; Li A; Lafleur M; Henderson JE
Am J Respir Crit Care Med; 2008 Feb; 177(3):309-15. PubMed ID: 18006890
[TBL] [Abstract][Full Text] [Related]
7. Enhanced F508del-CFTR channel activity ameliorates bone pathology in murine cystic fibrosis.
Le Henaff C; Haÿ E; Velard F; Marty C; Tabary O; Marie PJ; Jacquot JP
Am J Pathol; 2014 Apr; 184(4):1132-1141. PubMed ID: 24529904
[TBL] [Abstract][Full Text] [Related]
8. Osteoclastogenesis and sphingosine-1-phosphate secretion from human osteoclast precursor monocytes are modulated by the cystic fibrosis transmembrane conductance regulator.
Jourdain ML; Sergheraert J; Braux J; Guillaume C; Gangloff SC; Hubert D; Velard F; Jacquot J
Biochim Biophys Acta Mol Basis Dis; 2021 Mar; 1867(3):166010. PubMed ID: 33188942
[TBL] [Abstract][Full Text] [Related]
9. Running exercise alleviates trabecular bone loss and osteopenia in hemizygous β-globin knockout thalassemic mice.
Thongchote K; Svasti S; Teerapornpuntakit J; Krishnamra N; Charoenphandhu N
Am J Physiol Endocrinol Metab; 2014 Jun; 306(12):E1406-17. PubMed ID: 24780610
[TBL] [Abstract][Full Text] [Related]
10. Osteopenia in Cftr-deltaF508 mice.
Paradis J; Wilke M; Haston CK
J Cyst Fibros; 2010 Jul; 9(4):239-45. PubMed ID: 20570219
[TBL] [Abstract][Full Text] [Related]
11. CFTR mutations impart elevated immune reactivity in a murine model of cystic fibrosis related diabetes.
Stalvey MS; Brusko TM; Mueller C; Wasserfall CH; Schatz DA; Atkinson MA; Flotte TR
Cytokine; 2008 Oct; 44(1):154-9. PubMed ID: 18778952
[TBL] [Abstract][Full Text] [Related]
12. Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis.
Stotland PK; Radzioch D; Stevenson MM
Pediatr Pulmonol; 2000 Nov; 30(5):413-24. PubMed ID: 11064433
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor-4 genotype influences the survival of cystic fibrosis mice.
Canale-Zambrano JC; Auger ML; Haston CK
Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G381-90. PubMed ID: 20522639
[TBL] [Abstract][Full Text] [Related]
14. Iron Homeostasis and Inflammatory Status in Mice Deficient for the Cystic Fibrosis Transmembrane Regulator.
Deschemin JC; Allouche S; Brouillard F; Vaulont S
PLoS One; 2015; 10(12):e0145685. PubMed ID: 26709821
[TBL] [Abstract][Full Text] [Related]
15. Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies.
Jacquot J; Delion M; Gangloff S; Braux J; Velard F
Osteoporos Int; 2016 Apr; 27(4):1401-1412. PubMed ID: 26431978
[TBL] [Abstract][Full Text] [Related]
16. Mineral content of calcified tissues in cystic fibrosis mice.
Gawenis LR; Spencer P; Hillman LS; Harline MC; Morris JS; Clarke LL
Biol Trace Elem Res; 2001 Oct; 83(1):69-81. PubMed ID: 11694004
[TBL] [Abstract][Full Text] [Related]
17. Mapping of genetic factors influencing the weight of cystic fibrosis knockout mice.
Haston CK; Corey M; Tsui LC
Mamm Genome; 2002 Nov; 13(11):614-8. PubMed ID: 12461646
[TBL] [Abstract][Full Text] [Related]
18. Trabecular and cortical bone deficits are present in children and adolescents with cystic fibrosis.
Kelly A; Schall J; Stallings VA; Zemel BS
Bone; 2016 Sep; 90():7-14. PubMed ID: 27143111
[TBL] [Abstract][Full Text] [Related]
19. Very mild disease phenotype of congenic CftrTgH(neoim)Hgu cystic fibrosis mice.
Tóth B; Wilke M; Stanke F; Dorsch M; Jansen S; Wedekind D; Charizopoulou N; Bot A; Burmester M; Leonhard-Marek S; de Jonge HR; Hedrich HJ; Breves G; Tümmler B
BMC Genet; 2008 Apr; 9():28. PubMed ID: 18400105
[TBL] [Abstract][Full Text] [Related]
20. Skeletal overexpression of noggin results in osteopenia and reduced bone formation.
Devlin RD; Du Z; Pereira RC; Kimble RB; Economides AN; Jorgetti V; Canalis E
Endocrinology; 2003 May; 144(5):1972-8. PubMed ID: 12697704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]